Page 213 - Coronavirus Tests

At 2,026, Maha logs lowest Covid cases after Feb 2; 26 die, 5,389 recover

Maharashtra on Monday reported 2,026 fresh Covid-19 cases, the lowest after February 2, and 26 fatalities, taking the tally of infections to 65,62,514 and the death toll to 139,233

Experts say mass gatherings can worsen possible 3rd Covid wave

Data from Himachal Pradesh suggests that in a typical holiday season, tourism can increase the population by 40 per cent.

Kerala coronavirus update: 8,850 new Covid cases as fewer tests held

Kerala on Monday recorded 8,850 Covid cases as 74,871 samples were tested in the past 24 hours and the test positivity rate also fell to 11.82 per cent, said a statement from CM Pinarayi Vijayan

Disburse Rs 50k ex-gratia for Covid deaths within 30 days of applying: SC

The apex court asked the Centre and States to give wide publicity to the ex-gratia scheme.

4.2 mn people fully vaccinated, don't see 3rd wave coming: BMC tells HC

The Maharashtra government in August said it would initiate the drive and had started door-to-door vaccination of bed-ridden people as a pilot project

Maharashtra sees 2,692 Covid-19 cases, 2,716 recoveries, 41 fatalities

Maharashtra on Sunday reported 2,692 new coronavirus positive cases and 41 fatalities while 2,716 patients were discharged, the state health department said. The new additions pushed Maharashtra's COVID-19 tally to 65,59,349, the death toll to 1,39,207 and the number of recoveries to 63,80,670, it said, adding that the state is now left with 35,888 active cases. With 1,47,603 new tests, the number of samples examined in Maharashtra so far went up to 5,92,22,263. Mumbai city reported 573 COVID-19 cases and three deaths during the day, taking the tally of infections to 7,44,389 and the number of fatalities to 16,125, the department said. Mumbai division reported 1,053 more cases and four fatalities during the day which pushed the number of total cases in this region to 16,79,422 and the toll to 35,291. Nashik division reported 500 new cases including 424 in the Ahmednagar district. Pune division reported 809 cases, Kolhapur division 202, Aurangabad division 29, Latur division 73, A

Over 889.4 million Covid-19 vaccine doses provided to states, UTs: Centre

More than 889.4 million Covid vaccine doses have been provided to states and UTs so far, the Union Health Ministry said on Sunday.

India's active coronavirus cases stand at 270,557, lowest in 199 days

India added 22,842 new infections taking the total tally of Covid-19 cases to 33,813,903, while the active cases declined to 2,70,557, the lowest in 199 days

WHO to give approval to Covaxin this month, say top health experts

WHO's Strategic Advisory Group of Expert on Immunization (SAGE) will be conducting a meeting on October 5 regarding EUL to Covaxin.

Covid: Delhi records one death, 33 new cases; positivity rate 0.05%

On Friday, 32 cases were recorded with a positivity rate of 0.05 per cent and on Thursday, 47 cases were recorded with a positivity rate of 0.06 per cent.

Kerala logs 13,217 fresh coronavirus infections, 121 fatalities

There are 4,37,864 persons under observation of which 17,308 are in isolation wards of various hospitals.

Families committing suicide post Covid a matter of concern: Karnataka CM

Several instances have taken place where some family members ended their lives due to financial stress post COVID-19 lockdown

Over 900 mn Covid vaccine doses administered in India: Health minister

The country-wide vaccination drive was rolled out on January 16 with healthcare workers (HCWs) getting inoculated in the first phase.

Mizoram issues new Covid-19 guidelines with more relaxations

The new guidelines will come into effect on October 3 and will remain in force in the state till October 16

75 countries add to calls for global solidarity for vaccine equity

The pandemic knows no borders, the only solution lies in global solidarity, unity and multilateral cooperation, said the countries in a joint statement.

Covid-19 may trigger high sugar levels, worsen disease, says new study

Covid-19 infection triggers hyperglycemia, or high blood sugar levels, by disrupting key fat cells, bringing high risks of severe disease and death in many patients, according to a new study.

India registers 24,354 new Covid-19 cases, 234 fresh fatalities

India logged 24,354 new COVID-19 cases, taking the tally to 3,37,91,061, while the active cases declined to 2,73,889, according to the Union health ministry's data updated on Saturday. The death toll climbed to 4,48,573 with 234 fresh fatalities, according to the data updated at 8 am. The active cases comprise 0.81 per cent of the total infections, the lowest since March 2020, while the national COVID-19 recovery rate was recorded at 97.86 per cent, the highest since March 2020, the ministry said. A decrease of 1,335 Covid cases has been recorded in the total number of active cases in a span of 24 hours. India's COVID-19 tally had crossed the 20-lakh mark on August 7, 2020, 30 lakh on August 23, 40 lakh on September 5 and 50 lakh on September 16. It went past 60 lakh on September 28, 70 lakh on October 11, crossed 80 lakh on October 29, 90 lakh on November 20 and surpassed the one-crore mark on December 19. India crossed the grim milestone of two crore on May 4 and three crore on

Number of weekly Covid-19 cases, deaths continue to decline globally: WHO

The Covid-19 Weekly Epidemiological Update, released this week, said over 3.3 million new cases and over 55,000 new deaths were reported around the world during the week of September 2026, 2021

Covid: Merck's oral pill shows promise against hospitalisation, death

Merck & Co said Friday that its experimental COVID-19 pill reduced hospitalisations and deaths by half in people recently infected with the coronavirus and that it would soon ask health officials in the US and around the world to authorize its use. If cleared, Merck's drug would be the first pill shown to treat COVID-19, a potentially major advance in efforts to fight the pandemic. All COVID-19 therapies now authorised in the US require an IV or injection. Merck and its partner Ridgeback Biotherapeutics said early results showed patients who received the drug, called molnupiravir, within five days of COVID-19 symptoms had about half the rate of hospitalisation and death as patients who received a dummy pill. The study tracked 775 adults with mild-to-moderate COVID-19 who were considered higher risk for severe disease due to health problems such as obesity, diabetes or heart disease. Among patients taking molnupiravir, 7.3 per cent were either hospitalised or died at the end of 30 .

Covid: Delhi records 32 new cases, zero deaths; positivity rate 0.05%

The death toll due to the coronavirus infection in Delhi stands at 25,087